5Ozawa T,Paviour D,Quinn NP,et al.The spectrum of pathological involvement of the striatongral and olivopontocerebellar systems in maltiple system atrophy:clinicopathological correlations.Brain,2004,127:2657-2671.
6Jellinger KA.Neuropathological spectrum of synucleinopathies.Mor Disord,2003,18:2-12.
7Hiroyuki S,Ichiro Y,Asako T,et al.Heredity in multiple system atrophy.J Neurological Sciences,2006,240:107-110.
1Parikh SM,Diedrich A,Biaggioni I,et al.The nature of the autonomic dysfunction in multiple system atrophy.J Neurol Sci,2002,200:1-10.
2Gilman S,Low PA,Quinn N,et al.Consensus statement on the diagnosis of multiple system atrophy.J Auton Nerv Syst,1998,74:189-192.
3Riley DE,Chelimsky TC.Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson's disease.J Neurol Neurosurg Psychiatry,2003,74:56-60.
4Beck RO,Betts CD,Fowler CJ.Genitourinary dysfunction in multiple system atrophy:clinical features and treatment in 62 cases.J Urol,1994,151:1336-1341.
5Sakakibara R,Hattori T,Uchiyama T,et al.Urinary dysfunction and orthostatic hypotension in multiple system atrophy:which is the more common and earlier manifestation.J Neurol Neurosurg Psychiatry,2000,68:65-69.
6Kirchhof K,Apostolidis AN,Mathias CJ,et al.Erectile and urinary dysfunction may be the presenting features in patients with multiple system atrophy:a retrospective study.Inter J Impotence Res,2003,15:193-198.
7Marti MJ,Tolosa E,Campdelacreu J.Clinical overview of the synucleinopathies.Mov Disord,2003,18:S21-S27.
8Dev KK,Hofele K,Barbieri S,et al.Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease.Neuropharmacology,2003,45:14-44.
9Clayton DF,George JM.Synucleins in synaptic plasticity and neurodegenerative disorders.J Neurosci Res,1999,58:120-129.
10Jenco JM,Rawlingson A,Daniels B,et al.Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins.Biochemistry,1998,37: 4901-4909.
